Table 6 Correlation between maternal androgen levels in pregnancy and child cognitive function measured by WPPSI-III/WISC-IV sum scores
From: Cognitive function in metformin exposed children, born to mothers with PCOS – follow-up of an RCT
FIQ | VC | WM | PO | PS | |
|---|---|---|---|---|---|
Testosterone (T) at inclusion | .093 | .117 | −.084 | .036 | .076 |
T w 19 | .223 | .181 | .038 | .105 | .162 |
T w 32 | .205 | .156 | .144 | .060 | .158 |
T w 36 | .218 | .108 | .158 | .097 | .200 |
Androstenedione (A) at inclusion | .010 | .024 | −.073 | .001 | .005 |
A w 19 | .236 | .155 | .063 | .130 | .214 |
A w 32 | .232 | .163 | .190 | .104 | .165 |
A w 36 | .255 | .157 | .176 | .124 | .224 |
Free testosterone index (FTI) at inclusion | −.054 | .004 | −.096 | −.087 | −.042 |
FTI w 19 | .252 | .224 | .129 | .122 | .148 |
FTI w 32 | .228 | .117 | .166 | .100 | .156 |
FTI w 36 | .197 | .127 | .159 | .080 | .158 |